Epithelial–mesenchymal transition (EMT) plays key roles during lung development and
many lung diseases such as chronic obstructive pulmonary disease (COPD), lung cancer …

A growing number of patients with end-stage lung disease have benefited from lung
transplantation (LT). Improvements in organ procurement, surgical techniques and intensive …

Despite improvements, lung transplantation remains hampered by both a scarcity of donor
organs and by mortality following primary graft dysfunction (PGD). Since acute respiratory …

Bronchiolitis obliterans syndrome (BOS) may develop after either lung or haematopoietic
stem cell transplantation (HSCT), with similarities in histopathological features and clinical …

Chronic lung allograft dysfunction (CLAD) remains the major barrier to long‐term survival
after lung transplantation and improved insight into its underlying immunological …

Factors contributing to donor-specific HLA antibody (DSA) development after lung
transplantation have not been systematically evaluated. We hypothesized that the isolation …

Long-term survival after lung transplantation remains suboptimal due to chronic lung
allograft dysfunction (CLAD), a progressive scarring process affecting the graft. Although anti …

Background Chronic lung allograft dysfunction and its main phenotypes, bronchiolitis
obliterans syndrome (BOS) and restrictive allograft syndrome (RAS), are major causes of …

Chronic rejection after organ transplantation is defined as a humoral‐and cell‐mediated
immune response directed against the allograft. In lung transplantation, chronic rejection is …

Respiratory viral infection (RVI) in lung transplant recipients (LTRs) is a risk for chronic lung
allograft dysfunction (CLAD). We hypothesize that donor-derived cell-free DNA …